Open Access Green as soon as Postprint is submitted to ZB.
Hypereosinophilia with systemic manifestations under dupilumab and possibility of dual benralizumab and dupilumab therapy in patients with asthma and CRSwNP.
J. Allergy Clin. Immunol. Pract. 9, 4477-4479 (2021)
Impact Factor
Scopus SNIP
Scopus
Cited By
Cited By
Altmetric
8.861
1.651
9
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Scientific Article
Language
english
Publication Year
2021
HGF-reported in Year
2021
ISSN (print) / ISBN
2213-2198
e-ISSN
2213-2201
Quellenangaben
Volume: 9,
Issue: 12,
Pages: 4477-4479
Publisher
Elsevier
Publishing Place
Amsterdam [u.a.]
Reviewing status
Peer reviewed
Institute(s)
Institute of Lung Health and Immunity (LHI)
POF-Topic(s)
30202 - Environmental Health
Research field(s)
Lung Research
PSP Element(s)
G-501600-001
WOS ID
WOS:000729499700041
Scopus ID
85113631302
PubMed ID
34384930
Erfassungsdatum
2021-10-06